Simplify Logo

Full-Time

Director – Legal Counsel

Confirmed live in the last 24 hours

Cytokinetics

Cytokinetics

201-500 employees

Develops drugs for muscle function improvement

Hardware
Biotechnology
Healthcare

Compensation Overview

$257k - $285kAnnually

Senior, Expert

San Bruno, CA, USA

Category
Legal
Legal & Compliance
Required Skills
Communications
Requirements
  • JD degree.
  • Admitted to at least one state bar. Admitted to California bar or admitted as Registered In-House Counsel required.
  • Minimum of 6 years of experience as in-house counsel or associate at a major law firm with a background in biotechnology, pharma or healthcare related matters. A combination of both in-house and law firm experience is a plus. However, expertise in contract drafting and negotiation of complex contracts is a requirement.
  • Detailed-oriented with a high level of intellectual, professional and interpersonal agility and flexibility.
  • Excellent communication skills, both oral and written.
  • Well-organized and hardworking, with the ability to manage numerous projects simultaneously under deadline pressure.
  • Excellent analytical skills, with a strong ability to draft and review legal documents, analyze legal advice and apply legal advice to business needs.
  • Ability to form strong working relationships with all levels of management, employees, and partners while maintaining firm adherence to proper legal standards.
  • Team-oriented, sound judgment, self-motivation and willingness to take initiative.
Responsibilities
  • Draft and negotiate healthcare related contracts including clinical trial agreements, investigator-initiated study agreements, contract research organization (CRO) agreements, consulting and physician advisory board agreements, commercial and API supply agreements and research agreements with partners and academic institutions. Providing advice and counsel clients on the preparation of such agreements as well as the Company's rights and obligations under executed agreements.
  • Draft and negotiate distribution agreements, payor agreements, and specialty pharma purchase agreements.
  • Draft and negotiate supply agreements and material transfer agreements.
  • Background on SEC filings such as 10-Ks, 10-Qs, proxy materials and Form 4s is helpful as well.
  • Knowledge of federal, state, and international healthcare laws and regulations including global privacy (GDPR), California Privacy Act, FCPA and anti-bribery is helpful.

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

South San Francisco, California

Founded

1998

Growth & Insights
Headcount

6 month growth

0%

1 year growth

1%

2 year growth

21%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful Phase III trial results for aficamten in treating obstructive hypertrophic cardiomyopathy (HCM) highlight the company's potential for market leadership in this area.
  • The $575M funding from Royalty Pharma ensures strong financial support for the commercial launch of aficamten and further R&D activities.
  • Recent investments and stock offerings indicate strong investor confidence and provide additional capital for growth and development.

What critics are saying

  • The late-stage biopharmaceutical market is highly competitive, with significant pressure to bring drugs to market quickly and efficiently.
  • Dependence on the success of clinical trials and regulatory approvals poses inherent risks, as any setbacks could delay commercialization and revenue generation.

What makes Cytokinetics unique

  • Cytokinetics focuses on muscle function improvement for cardiovascular and neuromuscular diseases, a niche area with high unmet medical needs.
  • The company has a robust pipeline of small molecule muscle activators and inhibitors, setting it apart from competitors with more generalized drug portfolios.
  • Strategic funding collaborations, such as the $575M deal with Royalty Pharma, provide significant financial backing for their R&D and commercialization efforts.